← Back to Search

Friends & Family -ACCELERATION Program for Chronic Disease

N/A
Waitlist Available
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks, and 3 month follow-up
Awards & highlights

Study Summary

The ACCELERATION (ACtivity, smoking Cessation, healthy Eating and aLcohol Education, inteRvention, and motivATION) Program is a collaborative project in cancer and chronic disease prevention that has been designed by and will be delivered amongst cardiopulmonary rehabilitation and prevention programs and cancer centres in Ontario (ON), British Columbia (BC), Quebec (QC) and Nova Scotia (NS). This project is being funded by the Canadian Partnership Against Cancer, Health Canada and Heart and Stroke Foundation of Canada and in the amount of $2.4M over a 3 year period (October 2013 - September 2016). The ACCELERATION Program is a 12 week structured model of behavioural interventions and education around self-management and prevention that aims to access readily available and referable people for primary prevention intervention.This program aligns with current provincial, national and international chronic disease prevention and management strategies. The goal of the ACCELERATION program is to measurably and effectively change the risk factors and health behaviours known to impact cancer and other chronic diseases. Specifically we will aim to increase physical activity, reduce smoking, encourage healthy eating, and moderate alcohol consumption in about 3,000 participants across Canada over 3 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks, and 3 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks, and 3 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement in one or more of the Four Core Health Behaviors
Secondary outcome measures
Improvement in Risk Factors for Chronic Disease
Other outcome measures
Self-efficacy and Behavioural Readiness

Trial Design

2Treatment groups
Experimental Treatment
Group I: Friends & Family -ACCELERATION ProgramExperimental Treatment1 Intervention
This group includes family and friends of cancer survivors and family and friends of cardiac & COPD rehab patients. The intervention includes Motivational Communication for Health Behavior management
Group II: At Risk Group: ACCELERATION programExperimental Treatment1 Intervention
This "At Risk" Group will include ;People at risk of cancer referred from UHN partners and community practices. Also included in this group are; First Nations population of BC, Asians and South Asian populations from Greater Vancouver and the working population of the City of Richmond employees. At the Montreal site users of the YMCA with risk factors for, or family history of, cancer and other chronic diseases will be targeted. And finally, in Nova Scotia the "At Risk" Group will be identified as being at risk of cancer and other chronic diseases referred from community practices and from the workplace population of the Capital District Health Authority (CDHA). Intervention: Motivational Communication for Health Behavior management

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityOTHER
258 Previous Clinical Trials
80,854 Total Patients Enrolled
1 Trials studying Chronic Disease
150 Patients Enrolled for Chronic Disease
Sunnybrook Health Sciences CentreOTHER
656 Previous Clinical Trials
1,547,622 Total Patients Enrolled
5 Trials studying Chronic Disease
1,602 Patients Enrolled for Chronic Disease
University Health Network, TorontoLead Sponsor
1,468 Previous Clinical Trials
481,490 Total Patients Enrolled
1 Trials studying Chronic Disease
408 Patients Enrolled for Chronic Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~286 spots leftby Apr 2025